entertainment -WSS

entertainment

author：entertainment 2025-09-06 03:27:49 - browse：41995

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Swim instructor mom warns parents not to buy blue swimsuits for kids

WSS

Secretariat’s lessons for human medicine

Weight loss drugs aren’t covered by Obamacare. That may change

Biden targets hefty hospital 'facility fees' that often surprise patients

Measles policy set amid Florida outbreak alarms vaccine proponents

Biden targets hefty hospital 'facility fees' that often surprise patients

Create a giant ice tray with this foil pan hack to keep food cold this summer

Wikipedia

entertainment

explore

Bright Health sells Medicare Advantage business to Molina

Abridge raises $150m as clinical notes automation market heats up

How to save PrEP access — and even expand it

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Trump demands the U.S. pay no more for drugs than other countries … again

Judge agrees to delay next hearing in Trump classified documents case

Jerome Adams on the need for new antivirals for Covid

White House announces new plan to address the growing threat of xylazine in overdose crisis

Medical records are filled with copy

Weight loss drugs aren’t covered by Obamacare. That may change

explore

Researchers tackle phage therapy hurdles for wider adoption

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

Medicare Advantage enrollment hits roughly 33.4 million

Recent heat wave in the Mediterranean caused by climate change: Study

Biden’s NIH nominee is languishing in Congress

ACA's risk program benefits Blue Cross Blue Shield insurers

hotspot

focus

knowledge

entertainment